Last reviewed · How we verify

NCT07292948: PFTP

Pelvic Floor Training Program and Perineal Trauma During Vaginal Birth

Completed NA Last updated 18 December 2025
What this trial tests

NA trial testing Pelvic Floor Muscle Training Program in Perineal Trauma in 300 participants. Completed in 2 September 2025.

Timeline
2 December 2024
Primary endpoint
2 September 2025
2 September 2025

Quick facts

Lead sponsorMehmet Incebıyik
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment300
Start date2 December 2024
Primary completion2 September 2025
Estimated completion2 September 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mehmet Incebıyik

Who can join

Adults 18 to 36, female only, with Perineal Trauma or Pelvic Floor Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine whether a structured pelvic floor muscle training program during pregnancy can reduce perineal trauma during vaginal birth. Nulliparous pregnant women at 28 weeks of gestation or later were invited to participate. Women who chose to join the training program performed supervised pelvic floor exercises twice weekly and daily home exercises. Women who declined the program received standard antenatal care. The study compared rates of severe perineal tears (third- or fourth-degree lacerations), episiotomy, the duration of the second stage of labor, postpartum urinary incontinence, and neonatal outcomes between the two groups. The goal of the study is to evaluate whether pelvic floor training can improve maternal and neonatal birth outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of a pelvic floor training program on perineal trauma during birth: a patient-preference controlled clinical trial.
    İncebıyık M, Palalı İ, Er Y, Tammo Ö, et al · · 2026 · PMID 41942674 · DOI 10.1038/s41598-026-47603-6

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07292948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing